EUVIMEDSkopri EUVIMED
Open access

Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19

Rodrigo de Oliveira Formiga iD, Flávia C Amaral, Camila F Souza, Daniel A G B Mendes, Carlos W S Wanderley, Cristina B Lorenzini, Adara A Santos, Juliana Antônia, Lucas F Faria, Caio C Natale, Nicholas M Paula, Priscila C S Silva and 25 more

British Journal of Pharmacology · 2023

DOI: 10.1111/bph.16013 ↗

At a glance

Journal article in British Journal of Pharmacology, 2023. Written by Rodrigo de Oliveira Formiga and 36 co-authors. Institution: Department of Pharmacology, Federal University of Santa Catarina, Florianópolis, Brazil. Major MEDLINE topics: COVID-19, Sepsis. Cited 18 times so far (Crossref); 72 references. The full text is freely available in PubMed Central. Funded by: FIC NIH HHS, Howard Hughes Medical Institute, Fonds Wetenschappelijk Onderzoek.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and Purpose Neutrophil overstimulation plays a crucial role in tissue damage during severe infections. Because pathogen‐derived neuraminidase (NEU) stimulates neutrophils, we investigated whether host NEU can be targeted to regulate the neutrophil dysregulation observed in severe infections. Experimental Approach The effects of NEU inhibitors on lipopolysaccharide (LPS)‐stimulated neutrophils from healthy donors or COVID‐19 patients were determined by evaluating the shedding of surface sialic acids, cell activation, and reactive oxygen species (ROS) production. Re‐analysis of single‐cell RNA sequencing of respiratory tract samples from COVID‐19 patients also was carried out. The effects of oseltamivir on sepsis and betacoronavirus‐induced acute lung injury were evaluated in murine models. Key Results Oseltamivir and zanamivir constrained host NEU activity, surface sialic acid release, cell activation, and ROS production by LPS‐activated human neutrophils. Mechanistically, LPS increased the interaction of NEU1 with matrix metalloproteinase 9 (MMP‐9). Inhibition of MMP‐9 prevented LPS‐induced NEU activity and neutrophil response. In vivo, treatment with oseltamivir fine‐tuned neutrophil migration and improved infection control as well as host survival in peritonitis and pneumonia sepsis. NEU1 also is highly expressed in neutrophils from COVID‐19 patients, and treatment of whole‐blood samples from these patients with either oseltamivir or zanamivir reduced neutrophil overactivation. Oseltamivir treatment of intranasally infected mice with the mouse hepatitis coronavirus 3 (MHV‐3) decreased lung neutrophil infiltration, viral load, and tissue damage. Conclusion and Implications These findings suggest that interplay of NEU1–MMP‐9 induces neutrophil overactivation. In vivo, NEU may serve as a host‐directed target to dampen neutrophil dysfunction during severe infections.

Subjects

MeSH terms (MEDLINE)

COVID-19SepsisHumansMiceAnimalsOseltamivirZanamivirNeuraminidaseNeutrophilsMatrix Metalloproteinase 9Reactive Oxygen SpeciesLipopolysaccharides

Author keywords

COVID-19SARS-CoV-2metalloproteinase-9neuraminidaseneutrophiloseltamivirsepsissialic acidzanamivir

Substances

OseltamivirZanamivirNeuraminidaseMatrix Metalloproteinase 9Reactive Oxygen SpeciesLipopolysaccharides

Authors and institutions

  • Department of Pharmacology, Federal University of Santa Catarina, Florianópolis, Brazil.
  • Université de Paris, Institut Cochin, INSERM U1016, CNRS, Paris, France.
  • Laboratory of Immunobiology, Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianópolis, Brazil.
  • Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
  • Department of Clinical Medicine, Federal University of Santa Catarina, Florianópolis, Brazil.
  • Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.

ORCID profiles: Rodrigo de Oliveira Formiga, Felipe R S Santos, Fernando Q Cunha

Funding

  • FIC NIH HHS
  • Howard Hughes Medical Institute
  • Fonds Wetenschappelijk Onderzoek

Cite

APA

de Oliveira Formiga, R., Amaral, F. C., Souza, C. F., Mendes, D. A. G. B., Wanderley, C. W. S., Lorenzini, C. B., Santos, A. A., Antônia, J., Faria, L. F., Natale, C. C., Paula, N. M., Silva, P. C. S., Fonseca, F. R., Aires, L., Heck, N., Starick, M. R., Queiroz-Junior, C. M., Santos, F. R. S., de Souza, F. R. O., …, & Spiller, F. (2023). Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19. British Journal of Pharmacology. https://doi.org/10.1111/bph.16013

Vancouver

de Oliveira Formiga R, Amaral FC, Souza CF, Mendes DAGB, Wanderley CWS, Lorenzini CB, et al. Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19. British Journal of Pharmacology. 2023. doi:10.1111/bph.16013

BibTeX
@article{deOliveiraFormiga2023,
  author = {de Oliveira Formiga, Rodrigo and Amaral, Flávia C and Souza, Camila F and Mendes, Daniel A G B and Wanderley, Carlos W S and Lorenzini, Cristina B and Santos, Adara A and Antônia, Juliana and Faria, Lucas F and Natale, Caio C and Paula, Nicholas M and Silva, Priscila C S and Fonseca, Fernanda R and Aires, Luan and Heck, Nicoli and Starick, Márick R and Queiroz-Junior, Celso M and Santos, Felipe R S and de Souza, Filipe R O and Costa, Vivian V and Barroso, Shana P C and Morrot, Alexandre and Van Weyenbergh, Johan and Sordi, Regina and Alisson-Silva, Frederico and Cunha, Fernando Q and Rocha, Edroaldo L and Chollet-Martin, Sylvie and Hurtado-Nedelec, Maria Margarita and Martin, Clémence and Burgel, Pierre-Régis and Mansur, Daniel S and Maurici, Rosemeri and Macauley, Matthew S and Báfica, André and Witko-Sarsat, Véronique and Spiller, Fernando},
  title = {Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19},
  journal = {British Journal of Pharmacology},
  year = {2023},
  doi = {10.1111/bph.16013}
}
Start for free →